20
Covalent Laboratories Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is CEFPODOXIME PROXETIL USP, with a corresponding US DMF Number 29791.
Remarkably, this DMF maintains an Active status since its submission on September 14, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 27, 2017, and payment made on December 27, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II